Ancora Advisors, LLC Aveo Pharmaceuticals, Inc. Transaction History

Ancora Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$3.15 - $6.01 $18,329 - $34,972	5,819 Added 14.42%	46,169 $258,000
Q1 2022 May 13, 2022	SELL	$3.15 - $6.01 $18,329 - $34,972	-5,819 Reduced 12.6%	40,350 $295,000
Q2 2021 Aug 13, 2021	BUY	$6.21 - $7.45 $36,135 - $43,351	5,819 Added 14.42%	46,169 $304,000
Q1 2021 May 14, 2021	BUY	$5.97 - $15.28 $23,880 - $61,120	4,000 Added 11.0%	40,350 $295,000
Q2 2020 Aug 14, 2020	BUY	$3.47 - $9.99 $126,134 - $363,136	36,350 New	36,350 $187,000

Ticker AVEO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,676,000
Description
AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.